ANTH:OTCMKTS
Anthera Pharmaceuticals Inc
$0.00
0.00%
(0.00) 1D
Sep 2, 10:11:44 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ANTH...
Mkt. cap
30.00
Avg. vol.
1.67K
Volume
0.00
52-wk high
$0.00
52-wk low
$0.00
Shares outstanding
0.00
No. of employees
21
Mkt. cap
30.00
Avg. vol.
1.67K
Volume
0.00
52-wk high
$0.00
52-wk low
$0.00
Shares outstanding
0.00
No. of employees
21
Profile
Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases. Liprotamase, Anthera's leading drug candidate which is being developed for exocrine pancreatic insufficiency is currently in Phase 3 clinical trials, and A-623 for the treatment of IgA nephropathy is currently in Phase 2 clinical trial. Wikipedia
About Anthera Pharmaceuticals Inc
CEO-
Employees21
Founded2004
HeadquartersHayward, California, United States
SectorBiotechnology
Websiteanthera.com